SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-085280
Filing Date
2021-06-24
Accepted
2021-06-24 18:33:31
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120602-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2120602-1_3seq1.xml 3 4110
2 EXHIBIT 24 tm2120602d1_ex24.htm EX-24 8480
  Complete submission text file 0001104659-21-085280.txt   14300
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Issuer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 250 NORTH BRIDGE ROAD #11-01 RAFFLES CITY TOWER SINGAPORE U0 179101
Business Address 250 NORTH BRIDGE ROAD #11-01 RAFFLES CITY TOWER SINGAPORE U0 179101 65-68288050
Vertex Global HC Fund II Pte. Ltd. (Reporting) CIK: 0001868847 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40523 | Film No.: 211044105